In line with this, the deletion of the prodynorphin coding sequence in mice (Loacker et al., 2007) and low dynorphin levels in humans due to mutations in the promoter region (Stögmann et al., 2002; Gambardella et al., 2003) are associated with increased vulnerability to the development of epilepsy. Here, PDYN is linked to epilepsy.